Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.00 (0.00%)
Bid:
102.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £61.92m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Transaction in Own Shares

13 Oct 2021 07:00

RNS Number : 8621O
Crystal Amber Fund Limited
13 October 2021
 

13 October 2021

 

Crystal Amber Fund Limited

(the "Company")

 

Transaction in Own Shares

 

The Board of Crystal Amber Fund Limited announces that, in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 20 November 2020, on Tuesday 12 October 2021 the Company purchased 30,000 of its own ordinary shares of 1p each ("Ordinary Shares") at a price of 110.0 pence per share. These shares will be held as treasury shares.

 

Following this transaction, the total number of Ordinary Shares held as treasury shares by the Company is 16,202,762. The total number of Ordinary Shares in issue (excluding shares held as treasury shares) is 83,547,000.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the individual purchases made by Winterflood Securities on behalf of the Company as part of the buyback programme.

 

For further enquiries please contact:

 

Crystal Amber Fund Limited

Chris Waldron (Chairman)

Tel: 01481 742 742

 

Allenby Capital Limited - Nominated Adviser

David Worlidge /Liz Kirchner

Tel: 020 7167 6431

 

Winterflood Securities - Broker

Joe Winkley/Neil Langford

Tel: 020 3100 0160

 

Crystal Amber Advisers (UK) LLP - Investment Adviser

Richard Bernstein

Tel: 020 7478 9080

 

 

 

Schedule of Purchases

Shares purchased: Crystal Amber Fund Limited (ISIN CODE: GG00B1Z2SL48)

Date of purchases: 12 October 2021

Investment firm: Winterflood Securities

 

Aggregate information:

Venue

Volume-weighted

average price, pence

Aggregated volume

London Stock Exchange

110.0p

30,000

 

Individual transaction:

Number of shares purchased

Transaction price(pence per share)

Time of transaction

Trading venue

30,000

110.0p

16:43

London Stock Exchange

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFFDFWEEFSEDS
Date   Source Headline
20th May 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
19th May 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
16th May 20255:22 pmRNSTransaction in Own Shares and Total Voting Rights
15th May 20255:30 pmRNSMonthly Net Asset Value
15th May 20255:15 pmRNSTransaction in Own Shares and Total Voting Rights
6th May 202510:37 amRNSHolding(s) in Company
1st May 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20255:30 pmRNSTotal Voting Rights
25th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20255:15 pmRNSHolding(s) in Company
23rd Apr 20252:00 pmRNSHolding(s) in Company
22nd Apr 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 202511:00 amRNSHolding(s) in Company
22nd Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20256:00 pmRNSForm 8.3 - De La Rue plc
10th Apr 202511:00 amRNSForm 8.3 - De La Rue plc
9th Apr 20254:41 pmRNSForm 8.3 - De La Rue plc - Replacement
9th Apr 202510:00 amRNSForm 8.3 - De La Rue plc
8th Apr 202511:30 amRNSTransaction in Own Shares and Total Voting Rights
8th Apr 202510:30 amRNSForm 8.3 - De La Rue plc
7th Apr 202512:00 pmRNSForm 8.3 - De La Rue plc
7th Apr 202510:03 amRNSTransaction in Own Shares and Total Voting Rights
4th Apr 20252:27 pmRNSForm 8.3 - De La Rue plc - Replacement
4th Apr 202511:16 amRNSForm 8.3 - De La Rue plc
1st Apr 20258:43 amRNSTotal Voting Rights
31st Mar 20254:34 pmRNSMonthly Net Asset Value
27th Mar 20256:30 pmRNSTransaction in Own Shares and Total Voting Rights
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 202510:03 amRNSShare Buyback Programme
21st Mar 20257:00 amRNSHalf-year Report
14th Mar 20253:30 pmRNSCancellation of treasury shares
6th Mar 202511:58 amRNSForm 8.3 - De La Rue plc
28th Feb 20255:30 pmRNSTotal Voting Rights
24th Feb 20255:00 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Feb 20257:00 amRNSHolding(s) in Company
21st Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Feb 20254:23 pmRNSHolding(s) in Company
20th Feb 20257:00 amRNSUpdate on Morphic Medical Inc.
19th Feb 20255:13 pmRNSTransaction in Own Shares and Total Voting Rights
19th Feb 20255:06 pmRNSDirector/PDMR Shareholding
19th Feb 202510:18 amRNSForm 8.3 - De La Rue plc
18th Feb 20256:00 pmRNSMonthly Net Asset Value
18th Feb 20255:54 pmRNSTransaction in Own Shares and Total Voting Rights
17th Feb 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
13th Feb 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
13th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Feb 20256:00 pmRNSForm 8.3 - De La Rue plc
10th Feb 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.